Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Nov;78(9):1219–1223. doi: 10.1038/bjc.1998.658

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

P Autzen 1, C N Robson 1, A Bjartell 1, A J Malcolm 1, M I Johnson 1, D E Neal 1, F C Hamdy 1
PMCID: PMC2062993  PMID: 9820184

Abstract

Prostatic adenocarcinoma commonly metastasizes to bone. Unlike most other bony secondaries, the majority of skeletal prostatic metastases are osteoblastic rather than osteolytic in nature. Several growth factors which are known to stimulate bone formation are expressed in benign and malignant prostate cells, but none has been specifically linked to osteosclerotic metastases. Bone morphogenetic proteins (BMPs) induce ectopic bone formation in vivo. We have reported previously that BMP-6 mRNA and protein are expressed in the majority of primary prostatic carcinomas with established skeletal metastases but rarely in clinically organ-confined tumours. This study examines the expression of BMP-6 mRNA in matched prostatic primary and secondary bony lesions and in isolated skeletal metastases from prostatic adenocarcinomas, as well as other common human malignancies, by in situ hybridization. BMP-6 mRNA was detected in 11 out of 13 bone metastases from prostate carcinoma and in three paired samples of primary prostate carcinoma and matching skeletal metastasis. Weak signals for BMP-6 were also present in 5 out of 17 skeletal deposits from non-prostatic malignancies. BMP-6 mRNA appears to be strongly expressed in prostatic adenocarcinomas, both in the primary tumour and in bone metastases. It is also expressed, though less frequently, in skeletal metastases from other human carcinomas. Our findings suggest that BMP-6 may hold potential as an attractive marker and possible mediator of skeletal metastases, particularly in prostate carcinoma.

Full text

PDF
1219

Images in this article

1220Figure 1
on p.1220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes J., Anthony C. T., Wall N., Steiner M. S. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol. 1995;13(6):337–343. doi: 10.1007/BF00191214. [DOI] [PubMed] [Google Scholar]
  2. Bauer F. C., Urist M. R. Human osteosarcoma-derived soluble bone morphogenetic protein. Clin Orthop Relat Res. 1981 Jan-Feb;(154):291–295. [PubMed] [Google Scholar]
  3. Baylink D. J., Finkelman R. D., Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res. 1993 Dec;8 (Suppl 2):S565–S572. doi: 10.1002/jbmr.5650081326. [DOI] [PubMed] [Google Scholar]
  4. Boden S. D., McCuaig K., Hair G., Racine M., Titus L., Wozney J. M., Nanes M. S. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology. 1996 Aug;137(8):3401–3407. doi: 10.1210/endo.137.8.8754767. [DOI] [PubMed] [Google Scholar]
  5. Celeste A. J., Iannazzi J. A., Taylor R. C., Hewick R. M., Rosen V., Wang E. A., Wozney J. M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9843–9847. doi: 10.1073/pnas.87.24.9843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Galasko C. S. Mechanisms of lytic and blastic metastatic disease of bone. Clin Orthop Relat Res. 1982 Sep;(169):20–27. [PubMed] [Google Scholar]
  7. Gitelman S. E., Kobrin M. S., Ye J. Q., Lopez A. R., Lee A., Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol. 1994 Sep;126(6):1595–1609. doi: 10.1083/jcb.126.6.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hamdy F. C., Autzen P., Robinson M. C., Horne C. H., Neal D. E., Robson C. N. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res. 1997 Oct 1;57(19):4427–4431. [PubMed] [Google Scholar]
  9. Harris S. E., Harris M. A., Mahy P., Wozney J., Feng J. Q., Mundy G. R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate. 1994 Apr;24(4):204–211. doi: 10.1002/pros.2990240406. [DOI] [PubMed] [Google Scholar]
  10. Harris S. E., Sabatini M., Harris M. A., Feng J. Q., Wozney J., Mundy G. R. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J Bone Miner Res. 1994 Mar;9(3):389–394. doi: 10.1002/jbmr.5650090314. [DOI] [PubMed] [Google Scholar]
  11. Hughes F. J., Collyer J., Stanfield M., Goodman S. A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology. 1995 Jun;136(6):2671–2677. doi: 10.1210/endo.136.6.7750491. [DOI] [PubMed] [Google Scholar]
  12. Jensen O. M., Estève J., Møller H., Renard H. Cancer in the European Community and its member states. Eur J Cancer. 1990;26(11-12):1167–1256. doi: 10.1016/0277-5379(90)90278-2. [DOI] [PubMed] [Google Scholar]
  13. Jin Y., Yang L. J. Immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma. J Oral Pathol Med. 1990 Apr;19(4):152–154. doi: 10.1111/j.1600-0714.1990.tb00815.x. [DOI] [PubMed] [Google Scholar]
  14. Koutsilieris M., Rabbani S. A., Goltzman D. Effects of human prostatic mitogens on rat bone cells and fibroblasts. J Endocrinol. 1987 Dec;115(3):447–454. doi: 10.1677/joe.0.1150447. [DOI] [PubMed] [Google Scholar]
  15. LInd M., Eriksen E. F., Bünger C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone. 1996 Jan;18(1):53–57. doi: 10.1016/8756-3282(95)00423-8. [DOI] [PubMed] [Google Scholar]
  16. Lyons K. M., Pelton R. W., Hogan B. L. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development. 1990 Aug;109(4):833–844. doi: 10.1242/dev.109.4.833. [DOI] [PubMed] [Google Scholar]
  17. Lyons K. M., Pelton R. W., Hogan B. L. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev. 1989 Nov;3(11):1657–1668. doi: 10.1101/gad.3.11.1657. [DOI] [PubMed] [Google Scholar]
  18. Orr F. W., Sanchez-Sweatman O. H., Kostenuik P., Singh G. Tumor-bone interactions in skeletal metastasis. Clin Orthop Relat Res. 1995 Mar;(312):19–33. [PubMed] [Google Scholar]
  19. Perkel V. S., Mohan S., Herring S. J., Baylink D. J., Linkhart T. A. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells. Cancer Res. 1990 Nov 1;50(21):6902–6907. [PubMed] [Google Scholar]
  20. Saitoh H., Hida M., Shimbo T., Nakamura K., Yamagata J., Satoh T. Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer. 1984 Dec 15;54(12):3078–3084. doi: 10.1002/1097-0142(19841215)54:12<3078::aid-cncr2820541245>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  21. Stone C. A. A molecular approach to bone regeneration. Br J Plast Surg. 1997 Jul;50(5):369–373. doi: 10.1016/s0007-1226(97)90547-6. [DOI] [PubMed] [Google Scholar]
  22. Urist M. R. Bone: formation by autoinduction. Science. 1965 Nov 12;150(3698):893–899. doi: 10.1126/science.150.3698.893. [DOI] [PubMed] [Google Scholar]
  23. Urist M. R., DeLange R. J., Finerman G. A. Bone cell differentiation and growth factors. Science. 1983 May 13;220(4598):680–686. doi: 10.1126/science.6403986. [DOI] [PubMed] [Google Scholar]
  24. Urist M. R., Huo Y. K., Brownell A. G., Hohl W. M., Buyske J., Lietze A., Tempst P., Hunkapiller M., DeLange R. J. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A. 1984 Jan;81(2):371–375. doi: 10.1073/pnas.81.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Urist M. R., Lietze A., Mizutani H., Takagi K., Triffitt J. T., Amstutz J., DeLange R., Termine J., Finerman G. A. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop Relat Res. 1982 Jan-Feb;(162):219–232. [PubMed] [Google Scholar]
  26. Wang E. A., Rosen V., D'Alessandro J. S., Bauduy M., Cordes P., Harada T., Israel D. I., Hewick R. M., Kerns K. M., LaPan P. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2220–2224. doi: 10.1073/pnas.87.6.2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ware J. L. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 1993 Sep;12(3-4):287–301. doi: 10.1007/BF00665959. [DOI] [PubMed] [Google Scholar]
  28. Wingo P. A., Landis S., Ries L. A. An adjustment to the 1997 estimate for new prostate cancer cases. CA Cancer J Clin. 1997 Jul-Aug;47(4):239–242. doi: 10.3322/canjclin.47.4.239. [DOI] [PubMed] [Google Scholar]
  29. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J. M., Rosen V., Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 1996 Mar 18;220(2):366–371. doi: 10.1006/bbrc.1996.0411. [DOI] [PubMed] [Google Scholar]
  30. Yoshikawa H., Rettig W. J., Lane J. M., Takaoka K., Alderman E., Rup B., Rosen V., Healey J. H., Huvos A. G., Garin-Chesa P. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer. 1994 Aug 1;74(3):842–847. doi: 10.1002/1097-0142(19940801)74:3<842::aid-cncr2820740309>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  31. Yoshikawa H., Rettig W. J., Takaoka K., Alderman E., Rup B., Rosen V., Wozney J. M., Lane J. M., Huvos A. G., Garin-Chesa P. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer. 1994 Jan 1;73(1):85–91. doi: 10.1002/1097-0142(19940101)73:1<85::aid-cncr2820730116>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES